449 related articles for article (PubMed ID: 32031683)
1. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
Kumar S; Verma AK; Rani R; Sharma A; Wang J; Shah SA; Behari J; Salazar Gonzalez R; Kohli R; Gandhi CR
Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
Gandhi CR; Chaillet JR; Nalesnik MA; Kumar S; Dangi A; Demetris AJ; Ferrell R; Wu T; Divanovic S; Stankeiwicz T; Shaffer B; Stolz DB; Harvey SA; Wang J; Starzl TE
Gastroenterology; 2015 Feb; 148(2):379-391.e4. PubMed ID: 25448926
[TBL] [Abstract][Full Text] [Related]
3. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
4. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
Bala S; Ganz M; Babuta M; Zhuang Y; Csak T; Calenda CD; Szabo G
Lab Invest; 2021 Dec; 101(12):1540-1549. PubMed ID: 34453120
[TBL] [Abstract][Full Text] [Related]
5. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
Li G; Zhang J; Jiang Q; Liu B; Xu K
Life Sci; 2020 Aug; 254():117795. PubMed ID: 32417373
[TBL] [Abstract][Full Text] [Related]
6. Augmenter of liver regeneration: Mitochondrial function and steatohepatitis.
Verma AK; Sharma A; Subramaniyam N; Gandhi CR
J Hepatol; 2022 Nov; 77(5):1410-1421. PubMed ID: 35777586
[TBL] [Abstract][Full Text] [Related]
7. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
8. Protective role of cGAS in NASH is related to the maintenance of intestinal homeostasis.
de Carvalho Ribeiro M; Cho Y; Mehta J; Wang X; Babuta M; Copeland C; Hussein H; Catalano D; Wang Y; Szabo G
Liver Int; 2023 Sep; 43(9):1937-1949. PubMed ID: 37222257
[TBL] [Abstract][Full Text] [Related]
9. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
[TBL] [Abstract][Full Text] [Related]
10. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water.
Liu XJ; Duan NN; Liu C; Niu C; Liu XP; Wu J
Lab Invest; 2018 Sep; 98(9):1184-1199. PubMed ID: 29959418
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
[TBL] [Abstract][Full Text] [Related]
13. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water.
Zhu LY; Liu C; Li ZR; Niu C; Wu J
Lab Invest; 2021 May; 101(5):588-599. PubMed ID: 33526807
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
Kumar S; Wang J; Rani R; Gandhi CR
PLoS One; 2016; 11(1):e0147864. PubMed ID: 26808690
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
Kim MB; Lee Y; Bae M; Kang H; Pham TX; Hu S; Lee JY; Park YK
J Nutr Biochem; 2020 Nov; 85():108463. PubMed ID: 32891893
[TBL] [Abstract][Full Text] [Related]
17. Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.
Zheng M; Ai Z; Guo Y; Chen Y; Xie P; An W
Oncogene; 2023 Jan; 42(4):308-321. PubMed ID: 36434180
[TBL] [Abstract][Full Text] [Related]
18. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
20. IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.
Azuma YT; Fujita T; Izawa T; Hirota K; Nishiyama K; Ikegami A; Aoyama T; Ike M; Ushikai Y; Kuwamura M; Fujii H; Tsuneyama K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
